Simplify Aimovig Prior Authorization with Klivira Automation
Navigating Aimovig prior authorization can be a significant bottleneck for patient access to this critical preventive migraine therapy. Klivira automates the entire process, from submission to approval.
Revenue cycle directors and prior authorization coordinators face increasing pressure to manage complex drug PAs efficiently. For CGRP receptor antagonists like Aimovig (erenumab), specific payer requirements, including step therapy, often lead to delays and administrative burden, impacting both staff productivity and patient care.
The Challenge of Aimovig Prior Authorization
Aimovig, a CGRP receptor antagonist for chronic and episodic migraine, frequently requires prior authorization due to its specialty drug classification and cost. Payers often mandate specific clinical criteria, including failed trials of generic preventive therapies, creating a complex and time-consuming manual workflow for healthcare providers.
Common Aimovig PA Requirements
- Confirmation of chronic or episodic migraine diagnosis.
- Documentation of previous trials and failures of alternative preventive therapies (step therapy).
- Patient-specific clinical data, including migraine frequency and severity.
- Attestation of prescriber specialty or experience.
- Justification for continued therapy for renewal requests.
How Klivira Automates Aimovig Prior Authorization
Klivira integrates directly with your EMR and payer portals to automate the submission and tracking of Aimovig prior authorizations. Our platform intelligently identifies required clinical documentation, auto-populates forms, and manages communication with payers, significantly reducing manual touchpoints and accelerating approval times.
Seamless EMR and Payer Portal Integration
Klivira leverages industry standards like SMART on FHIR and X12 278 transactions to ensure robust connectivity. This allows for real-time data exchange, eliminating duplicate data entry and ensuring that all necessary patient information for Aimovig (erenumab) PA is accurately and securely transmitted from your system to the payer.
Ensuring Data Security and Compliance
Handling PHI for prior authorizations demands stringent security protocols. Klivira is built with HIPAA compliance at its core, employing robust encryption, access controls, and audit trails. Our platform ensures that all ePHI related to Aimovig PA requests is protected throughout the automation workflow, aligning with your organization's compliance framework.
Key Benefits of Klivira for Aimovig PA
- Accelerated Approvals: Reduce turnaround times for Aimovig PA decisions.
- Reduced Administrative Burden: Free up PA coordinators from repetitive manual tasks.
- Improved Accuracy: Minimize errors with automated data extraction and form population.
- Enhanced Patient Access: Expedite access to critical migraine therapy (erenumab).
- Real-time Visibility: Track PA status across all payers from a single dashboard.
Frequently asked questions
What is Aimovig (erenumab) and what are its indications?
Aimovig (erenumab) is a CGRP receptor antagonist, a class of medication specifically designed for the preventive treatment of migraine. It is indicated for both chronic migraine and episodic migraine, targeting a key pathway involved in migraine pathophysiology.
Why is prior authorization typically required for Aimovig?
As a specialty medication, Aimovig often carries a significant cost, leading payers to implement prior authorization requirements. These typically involve demonstrating medical necessity, often through step therapy protocols where patients must first try and fail generic or less costly preventive migraine treatments.
How does Klivira address step therapy requirements for Aimovig?
Klivira's platform is configured to understand and apply payer-specific step therapy rules for drugs like Aimovig. It prompts for and extracts documentation of previous treatment failures directly from the EMR, ensuring that all necessary clinical evidence is included in the initial PA submission, reducing denials and appeals.
Which EMR systems does Klivira integrate with for Aimovig prior authorizations?
Klivira provides robust integration capabilities with leading EMR systems, including Epic, Cerner, MEDITECH, and athenahealth, utilizing standards like SMART on FHIR. This enables seamless exchange of patient data required for Aimovig PA directly from your clinical workflows.
Can Klivira integrate with specific payer portals for Aimovig PA submissions?
Yes, Klivira integrates with a wide range of payer portals and utilizes various electronic prior authorization (ePA) channels, including X12 278 and NCPDP SCRIPT, to submit Aimovig PA requests. This ensures comprehensive coverage across your payer mix, streamlining submissions regardless of payer-specific requirements.
Related coverage
Simplify prior authorization by payer
- Navigating Aetna Aimovig Prior Authorization for Migraine Therapy
- Navigating Anthem (Elevance Health) Aimovig Prior Authorization
- Navigating Centene Aimovig Prior Authorization for Migraine Treatment
- Cigna Aimovig Prior Authorization: Automating Approval Workflows
- Navigating Humana Aimovig Prior Authorization: A Provider's Guide
- Optimizing Kaiser Permanente Aimovig Prior Authorization Workflows
- Streamlining Medicaid Aimovig Prior Authorization Workflows
- Streamlining Medicare Aimovig Prior Authorization
- Molina Healthcare Aimovig Prior Authorization: A Klivira Guide
- Navigating UnitedHealthcare Aimovig Prior Authorization
Simplify prior authorization by specialty
- Streamlining Aimovig Prior Authorization for Cardiology-Integrated Workflows
- Streamlining Aimovig Prior Authorization for Dermatology Practices
- Optimizing Aimovig Prior Authorization for Endocrinology Practices
- Aimovig Prior Authorization for Gastroenterology: Navigating Co-Morbidities and PA Complexity
- Navigating Aimovig Prior Authorization for Hematology Practices
- Aimovig Prior Authorization for Neurology: Optimizing CGRP Biologic Approvals
- Aimovig Prior Authorization for Oncology: Navigating Comorbidity PAs
- Aimovig Prior Authorization for Ophthalmology: Streamlining Specialty Drug Approvals
- Aimovig Prior Authorization for Orthopedics: Streamlining Specialty Drug Approvals
- Aimovig Prior Authorization for Pain Management: A Klivira Perspective
- Navigating Aimovig Prior Authorization for Psychiatry Practices
- Optimizing Aimovig Prior Authorization for Pulmonology Practices
- Aimovig Prior Authorization for Radiation Oncology: Navigating Approval
- Aimovig Prior Authorization for Rheumatology
Ready to automate prior auth for this drug?
See how Klivira automates prior authorizations for your team.
Request a demo